Trending NewsTrending NewsMost-Upgraded StocksMost-UpgradedNASDAQ:GH Guardant Health (GH) Stock Price, News & Analysis $179.38 -3.72 (-2.03%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$179.25 -0.13 (-0.07%) As of 09/18/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Guardant Health Stock (NASDAQ:GH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Guardant Health alerts:Sign Up Key Stats Today's Range$175.62▼$183.5050-Day Range$143.62▼$183.1052-Week Range$55.38▼$183.51Volume3.08 million shsAverage Volume1.71 million shsMarket Capitalization$24.07 billionP/E RatioN/ADividend YieldN/APrice Target$188.13Consensus RatingModerate Buy Company Overview Guardant Health, Inc. (NASDAQ:GH) is a precision oncology company that develops blood-based diagnostic tests designed to help detect cancer, guide treatment decisions and monitor patients over time. Its liquid biopsy technologies analyze tumor-related signals in blood, reducing the need for tissue biopsies in certain clinical and research settings. The company’s products include Guardant360 tests, which profile advanced cancers and can help identify potentially actionable genomic alterations; Guardant Reveal, which is used to assess residual disease and recurrence risk; and Guardant Shield, a blood-based screening test for colorectal cancer. Guardant also provides testing and data services to biopharmaceutical companies developing cancer treatments and conducting clinical research. Founded in 2012 and headquartered in Palo Alto, California, Guardant Health serves healthcare providers, patients, biopharmaceutical companies and researchers. Its commercial and research activities primarily focus on the United States, with its tests and services also supporting international oncology and drug-development markets.AI Generated. May Contain Errors. Read More Guardant Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreGH MarketRank™: Guardant Health scored higher than 41% of companies evaluated by MarketBeat, and ranked 615th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingGuardant Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.96, and is based on 1 strong buy rating, 24 buy ratings, no hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Guardant Health is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageGuardant Health has been the subject of 20 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Guardant Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Guardant Health are expected to grow in the coming year, from ($2.98) to ($2.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardant Health is -51.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardant Health is -51.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Guardant Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.72% of the float of Guardant Health has been sold short.Short Interest Ratio / Days to CoverGuardant Health has a short interest ratio ("days to cover") of 5.25.Change versus previous monthShort interest in Guardant Health has recently decreased by 1.26%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardant Health does not currently pay a dividend.Dividend GrowthGuardant Health does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.18 News SentimentGuardant Health has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Guardant Health this week, compared to 9 articles on an average week.Search InterestOnly 15 people have searched for GH on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat Follows13 people have added Guardant Health to their MarketBeat watchlist in the last 30 days. This is an increase of 117% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $69,813,286.00 in company stock.Percentage Held by Insiders5.60% of the stock of Guardant Health is held by insiders.Percentage Held by Institutions92.60% of the stock of Guardant Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Guardant Health's insider trading history. Receive GH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GH Stock News HeadlinesDarya Chudova Sells 7,738 Shares of Guardant Health (NASDAQ:GH) StockSeptember 19 at 4:22 AM | americanbankingnews.comGuardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy RoleSeptember 18 at 10:05 AM | finance.yahoo.comTrump and Bernie agree on thisDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.September 20 at 1:00 AM | Porter & Company (Ad)Guardant Health (NASDAQ:GH) Director Sells $20,300.00 in StockSeptember 18 at 7:37 AM | insidertrades.comGuardant Health (NASDAQ:GH) and Joint (NASDAQ:JYNT) Critical ComparisonSeptember 18 at 5:16 AM | americanbankingnews.comGuardant Health Nears Buy Point As Sales Outlook BrightensSeptember 16, 2026 | investors.comTesting & diagnostics services stocks Q2 results: Benchmarking Guardant Health (NASDAQ:GH)September 16, 2026 | msn.comGuardant Health (NASDAQ:GH) CEO Amirali Talasaz Sells 37,500 SharesAugust 25, 2026 | insidertrades.comSee More Headlines GH Stock Analysis - Frequently Asked Questions How have GH shares performed this year? Guardant Health's stock was trading at $102.14 on January 1st, 2026. Since then, GH shares have increased by 75.6% and is now trading at $179.38. How were Guardant Health's earnings last quarter? Guardant Health, Inc. (NASDAQ:GH) announced its quarterly earnings data on Thursday, July, 30th. The company reported ($0.42) EPS for the quarter, beating the consensus estimate of ($0.76) by $0.34. The business's quarterly revenue was up 44.3% compared to the same quarter last year. Read the conference call transcript. When did Guardant Health IPO? Guardant Health (GH) raised $200 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Who are Guardant Health's major shareholders? Guardant Health's top institutional shareholders include The Manufacturers Life Insurance Company (1.04%), William Blair Investment Management LLC (0.98%), Alyeska Investment Group L.P. (0.48%) and First Light Asset Management LLC (0.33%). Insiders that own company stock include Helmy Eltoukhy, Darya Chudova, Chris Freeman, Michael Brian Bell, Amirali Talasaz, John G Saia, Terilyn J Monroe, Myrtle S Potter, Kumud Kalia, Musa Tariq, Meghan V Joyce, Steve E Krognes, Medina Manuel Hidalgo, Ian T Clark and Alex M Azar II. View institutional ownership trends. How do I buy shares of Guardant Health? Shares of GH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardant Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardant Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Salesforce (CRM), Advanced Micro Devices (AMD), CrowdStrike (CRWD) and Adobe (ADBE). Company Calendar Last Earnings7/30/2026Today9/20/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 GH's financial health is in the Green zone, according to TradeSmith. GH has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:GH CIK1576280 Webwww.guardanthealth.com Phone(855) 698-8887Fax888-974-4258Employees2,506Year Founded2012Price Target and Rating Average Price Target for Guardant Health$188.13 High Price Target$225.00 Low Price Target$120.00 Potential Upside/Downside+4.9%Consensus RatingModerate Buy Rating Score (0-4)2.96 Research Coverage26 Analysts Profitability EPS (Trailing Twelve Months)($3.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$416.28 million Net Margins-38.33% Pretax Margin-38.41% Return on EquityN/A Return on Assets-25.40% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio3.71 Sales & Book Value Annual Sales$982.02 million Price / Sales24.51 Cash FlowN/A Price / Cash FlowN/A Book Value($0.79) per share Price / Book-227.06Miscellaneous Outstanding Shares134,200,000Free Float126,681,000Market Cap$24.07 billion OptionableNot Optionable Beta1.57 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:GH) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredWhy This Small AI Company Holds 150 PatentsJeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredNo Wallstreet. No Advisor. No Problem.Savings accounts pay just 0.58 percent interest. Andy Howard, co-founder of Meridian Capital, says liquidity p...Awesomely | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GH Stock Alerts